Stocks were firm on Tuesday morning during a shortened week that actually will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week for new ideas for our readers. Some of the analyst research reports cover stocks to buy, and some of them cover stocks to sell or to avoid.
As the second half of 2014 has begun, we had a look at the best performing DJIA stocks and also the best performing S&P 500 stocks so far in 2014. These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.
AbbVie Inc. (NYSE: ABBV) was raised to Overweight from Equal Weight and the price target was raised to $69 from $44 at Barclays.
Alcatel-Lucent S.A. (NYSE: ALU) was raised to Overweight from Neutral at J.P. Morgan.
Apple Inc. (NASDAQ: AAPL) was reiterated as Overweight and the price target was raised to $115 at Evercore partners.
Beazer Homes USA Inc. (NYSE: BZH) was downgraded to Neutral from Buy at Sterne Agee after the firm’s price target was achieved, even though earnings estimates were raised in the call.
Bristol-Myers Squibb Co. (NYSE: BMY) was downgraded to Equal Weight from Overweight at Barclays.